• Something wrong with this record ?

European Nephrologists' Attitudes toward the Application of Artificial Intelligence in Clinical Practice: A Comprehensive Survey

M. Savoia, G. Tripepi, B. Goethel-Paal, ME. Baró Salvador, P. Ponce, D. Voiculescu, M. Pachmann, T. Jirka, SK. Koc, W. Marcinkowski, M. Cioffi, L. Neri, L. Usvyat, JL. Hymes, FW. Maddux, C. Zoccali, S. Stuard

. 2024 ; 53 (2) : 80-87. [pub] 20231124

Language English Country Switzerland

Document type Journal Article

Persistent link   https://www.medvik.cz/link/bmc24007781

INTRODUCTION: The rapid advancement of artificial intelligence and big data analytics, including descriptive, diagnostic, predictive, and prescriptive analytics, has the potential to revolutionize many areas of medicine, including nephrology and dialysis. Artificial intelligence and big data analytics can be used to analyze large amounts of patient medical records, including laboratory results and imaging studies, to improve the accuracy of diagnosis, enhance early detection, identify patterns and trends, and personalize treatment plans for patients with kidney disease. Additionally, artificial intelligence and big data analytics can be used to identify patients' treatment who are not receiving adequate care, highlighting care inefficiencies in the dialysis provider, optimizing patient outcomes, reducing healthcare costs, and consequently creating values for all the involved stakeholders. OBJECTIVES: We present the results of a comprehensive survey aimed at exploring the attitudes of European physicians from eight countries working within a major hemodialysis network (Fresenius Medical Care NephroCare) toward the application of artificial intelligence in clinical practice. METHODS: An electronic survey on the implementation of artificial intelligence in hemodialysis clinics was distributed to 1,067 physicians. Of the 1,067 individuals invited to participate in the study, 404 (37.9%) professionals agreed to participate in the survey. RESULTS: The survey showed that a substantial proportion of respondents believe that artificial intelligence has the potential to support physicians in reducing medical malpractice or mistakes. CONCLUSION: While artificial intelligence's potential benefits are recognized in reducing medical errors and improving decision-making, concerns about treatment plan consistency, personalization, privacy, and the human aspects of patient care persist. Addressing these concerns will be crucial for successfully integrating artificial intelligence solutions in nephrology practice.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24007781
003      
CZ-PrNML
005      
20240423160245.0
007      
ta
008      
240412s2024 sz f 000 0|eng||
009      
AR
024    7_
$a 10.1159/000534604 $2 doi
035    __
$a (PubMed)38008072
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Savoia, Matteo $u Fresenius Medical Care, Global Medical Office, Bad Homburg, Germany
245    10
$a European Nephrologists' Attitudes toward the Application of Artificial Intelligence in Clinical Practice: A Comprehensive Survey / $c M. Savoia, G. Tripepi, B. Goethel-Paal, ME. Baró Salvador, P. Ponce, D. Voiculescu, M. Pachmann, T. Jirka, SK. Koc, W. Marcinkowski, M. Cioffi, L. Neri, L. Usvyat, JL. Hymes, FW. Maddux, C. Zoccali, S. Stuard
520    9_
$a INTRODUCTION: The rapid advancement of artificial intelligence and big data analytics, including descriptive, diagnostic, predictive, and prescriptive analytics, has the potential to revolutionize many areas of medicine, including nephrology and dialysis. Artificial intelligence and big data analytics can be used to analyze large amounts of patient medical records, including laboratory results and imaging studies, to improve the accuracy of diagnosis, enhance early detection, identify patterns and trends, and personalize treatment plans for patients with kidney disease. Additionally, artificial intelligence and big data analytics can be used to identify patients' treatment who are not receiving adequate care, highlighting care inefficiencies in the dialysis provider, optimizing patient outcomes, reducing healthcare costs, and consequently creating values for all the involved stakeholders. OBJECTIVES: We present the results of a comprehensive survey aimed at exploring the attitudes of European physicians from eight countries working within a major hemodialysis network (Fresenius Medical Care NephroCare) toward the application of artificial intelligence in clinical practice. METHODS: An electronic survey on the implementation of artificial intelligence in hemodialysis clinics was distributed to 1,067 physicians. Of the 1,067 individuals invited to participate in the study, 404 (37.9%) professionals agreed to participate in the survey. RESULTS: The survey showed that a substantial proportion of respondents believe that artificial intelligence has the potential to support physicians in reducing medical malpractice or mistakes. CONCLUSION: While artificial intelligence's potential benefits are recognized in reducing medical errors and improving decision-making, concerns about treatment plan consistency, personalization, privacy, and the human aspects of patient care persist. Addressing these concerns will be crucial for successfully integrating artificial intelligence solutions in nephrology practice.
650    _2
$a lidé $7 D006801
650    12
$a umělá inteligence $7 D001185
650    _2
$a nefrologové $7 D000072104
650    _2
$a dialýza ledvin $7 D006435
650    _2
$a průzkumy a dotazníky $7 D011795
650    12
$a nefrologie $7 D009398
655    _2
$a časopisecké články $7 D016428
700    1_
$a Tripepi, Giovanni $u Clinical Epidemiology of Renal Diseases and Hypertension Unit, Consiglio Nazionale delle Ricerche Institute of Clinical Physiology, Reggio Calabria, Italy
700    1_
$a Goethel-Paal, Berit $u Fresenius Medical Care, Global Medical Office, Bad Homburg, Germany
700    1_
$a Baró Salvador, Maria Eva $u Fresenius Medical Care, Global Medical Office, Madrid, Spain
700    1_
$a Ponce, Pedro $u Fresenius Medical Care, Global Medical Office, Lisbon, Portugal
700    1_
$a Voiculescu, Daniela $u Fresenius Medical Care, Global Medical Office, Bucharest, Romania
700    1_
$a Pachmann, Martin $u Fresenius Medical Care, Global Medical Office, Bad Homburg, Germany
700    1_
$a Jirka, Tomas $u Fresenius Medical Care, Global Medical Office, Praha, Czechia
700    1_
$a Koc, Serkan Kubilay $u Fresenius Medical Care, Global Medical Office, Istanbul, Turkey
700    1_
$a Marcinkowski, Wojciech $u Fresenius Medical Care, Global Medical Office, Warsaw, Poland
700    1_
$a Cioffi, Mario $u Fresenius Medical Care, Global Medical Office, Naples, Italy
700    1_
$a Neri, Luca $u Fresenius Medical Care, Global Medical Office, Bad Homburg, Germany
700    1_
$a Usvyat, Len $u Fresenius Medical Care, Global Medical Office, Waltham, Massachusetts, USA
700    1_
$a Hymes, Jeffrey L $u Fresenius Medical Care, Global Medical Office, Waltham, Massachusetts, USA
700    1_
$a Maddux, Franklin W $u Fresenius Medical Care, Global Medical Office, Waltham, Massachusetts, USA
700    1_
$a Zoccali, Carmine $u Institute of Biology and Molecular Genetics (BIOGEM), Ariano Irpino, Italy $u Associazione Ipertensione Nefrologia e Trapianto Renale (IPNET), Reggio Calabria, Italy
700    1_
$a Stuard, Stefano $u Fresenius Medical Care, Global Medical Office, Bad Homburg, Germany
773    0_
$w MED00000812 $t Blood purification $x 1421-9735 $g Roč. 53, č. 2 (2024), s. 80-87
856    41
$u https://pubmed.ncbi.nlm.nih.gov/38008072 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20240412 $b ABA008
991    __
$a 20240423160242 $b ABA008
999    __
$a ok $b bmc $g 2081645 $s 1217548
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 53 $c 2 $d 80-87 $e 20231124 $i 1421-9735 $m Blood purification $n Blood Purif $x MED00000812
LZP    __
$a Pubmed-20240412

Find record

Citation metrics

Archiving options